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The remarkable secretory capabilities of the
human eccrine sweat glands have long interested
all students of cutaneous physiology. However,
despite intensive study of the sweat glands over
the course of many years, there is still no clear
understanding of all of the mechanisms involved
in sweat secretion (1). It is generally believed
that eccrine sweat is derived from the extra-
cellular fluid and that plasma levels of electro-
lytes bear no direct relationship to the levels of
such substances in the sweat. However, some
studies seem to support the notion that deriva-
tion of electrolytes by the sweat glands directly
from the blood takes place (2), although it is
not to be implied that filtration akin to that of
the renal glomerulus occurs. Moreover, the sweat
gland tubule is endowed with an intimately-
woven vascular supply from which it could
conceivably filter its merocrine product. Histo-
logically, one is able to perceive two readily
distinguishable types of secretory cells in the
eccrine tubule (3), but there is no knowledge of
the function of either in the secretion of sweat.
Finally, the conceived role of the eccrine duct
as an absorptive mechanism regulating electro-
lyte concentration in the sweat (4) has also never
been fully clarified.
Within recent years, the attention of clinicians
and physiologists has been more sharply focused
on the process of eccrine secretion as a result of
the abnormal electrolyte loss that occurs in the
sweat of patients with cystic fibrosis. This ab-
normality has proved to be the most valid single
laboratory sign of the disease and reflects a basic
secretory defect throughout the exocrine system
of these patients.
The need for a better understanding of eccrine
sweat secretion both in normals and in patients
with cystic fibrosis prompted the present in-
vestigative program. In particular it was realized
that new technical approaches for the evaluation
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of sweat gland function were required. With this
in mind, our efforts were directed at a study of
the excretion or "clearance" by the sweat glands
of locally and/or parenterally administered
dyes. Such dye excretion has long been used in
the analysis of renal and hepatic function. Al-
though we had had some experience with the
excretion of locally-introduced methylene blue
in eccrine sweat (5), we knew of no studies of
the possible excretion of any other dyes in sweat.
Thus, our initial investigation involved the
screening of all of the available biological dyes
of low toxicity, to determine those which were
excreted by the sweat glands. Following this an
elucidation of the various factors affecting dye
excretion in sweat was undertaken. Finally, the
developed techniques were applied to an exami-
nation of certain aspects of sweat secretion in
man.
MATERIALS AND METHODS
Fifty-seven healthy adult male subjects,
ranging in age from 25 to 57 years, were used in this
investigation. Both Negroes and Whites were
included. Unless otherwise indicated, the volar
aspects of the forearms were used as the test areas
throughout these studies. The diluent employed
for the dye solutions and for the drugs was isotonic
saline. In general all solutions were buffered to
pH 7.2 (Sorenson's phosphate buffer) to minimize
local pain of the injections, which were given
through tuberculin syringes and %26 gauge
needles. Visualization of the test areas was made
grossly and with the aid of a hand lens (5 X) or
dissecting microscope (20 X). The observations
were in all cases of a qualitative or semiquantita-
tive nature and no precise quantitation of dye
concentration was made. Experiments were
carried out during all seasons of the year, at room
temperature (20°—25°C.). There was no humidity
control although the room was well-ventilated.
In order to minimize evaporation and spreading
of sweat droplets, the test areas were routinely
covered with castor oil. The latter was properly
viscid and hydrophobic. It was found that hydro-
philic "oily" substances, such as glycerine, could
not be used because the sweat droplets and ex-
creted dyes were soon solubilized by the covering
film and no longer visible. Biopsy specimens were
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secured under local 1% procaine anesthesia with
5 mm. punches.
I. Survey of Dyes For Excretion in Sweat
It was mentioned earlier that in previous work
we had utilized methylene blue in studies in-
volving the sweat glands. A 1% concentration
dye was used in those studies. In the present
experiments it was determined that 0.05%
concentration of methylene blue was optimal.
Increasing the concentration of dye did not
significantly deepen the color of the excreted
methylene blue in the sweat. In addition, it
was found that below a concentration of 0.1%
the anti-cholinergic effect of methylene blue (6)
on the sweat glands was negligible. Finally, at
this concentration (0.05%) the blue color of the
dye deposited in the skin test site usually faded
completely within 5—6 days. Stronger concen-
trations produced longer-lasting tatto-like areas
of discoloration. On the basis of these observa-
tions with methylene blue, we employed 0.05%
concentrations of all of the other dyes to deter-
mine their excretion in eecrine sweat. In those
instances in which this concentration resulted in
an appreciably lighter dye solution grossly, the
concentration of the dye was increased until an
adequate, grossly-comparable color intensity
was reached. The dyes and their test concentra-
tions as well as the results of the tests for excre-
tion in eccrine sweat are listed in Table I. The
following test format for the study of dye excre-
tion was employed routinely in all of these
experiments.
1. 0.03 cc. of the test dye solution was also
injected intradermally on symmetrical sites of
each forearm.
2. 0.03 cc. of 0.05% methylene blue solution
was also injected into the skin of each forearm
on symmetrical sites, 13 inches distal to the
other dye injections.
3. After an interval of 5—15 minutes 0.03 cc.
of 1:1,000 pilocarpine nitrate was injected intra-
dermally into both dye-treated sites of one fore-
arm and an equal quantity of 1:1,000 physostig-
mine salicylate introduced into the dye-treated
sites of the opposite forearm.
The methylene blue was used as a control in
all of these experiments to detect any possible
functional abnormalities of sweat secretion
amongst the various test subjects. At least three
subjects were studied with each of the test dyes.
As a result of these studies it was determined
that the following dyes were excreted readily,
i.e., in sufficient concentration to be promptly
visualized, by the sweat glands:
Methylene Blue
Azure B
Azure C
Toluidine Blue 0
Brilliant Cresyl Blue
Nile Blue A
Neutral Red
Fluoreseein
The methylene blue preparations containing
zinc were excreted as freely as were the less toxic
zinc-free forms of the dye. A number of the other
dyes, such as Azure A, and Gentian Violet, were
excreted in much reduced concentrations, barely
visible with our visualization technique. It was
felt that these dyes would not be useful in the
study of sweat gland function.
COMMENT
This survey study failed to reveal any requisite
chemical configuration common to all of the
excretable dyes. To be certain, members of the
quinone-imine group, especially the thiazins,
were readily excreted by the sweat glands. There
were exceptions however, as in the case of cresyl
violet and sefranin. If these substances were
present in the sweat, their concentration was
markedly reduced or they had been chemically
altered by the sweat glands so as to render them
colorless. In view of the excretion of the other
quinone-imine dyes, these possibilities seem
unlikely, however.
A perusal of the results with the quinone-
imine dyes tested, revealed that nigrosin and
all of the thiazins not excreted by the sweat
glands, were poorly soluble in water, It is not
difficult to understand that the property of
water-solubiity would be necessary for dye
excretion in eccrine sweat.
After repeated studies with the easily excreted
dyes listed above, it was found that methylene
blue and fluorescein were the most valuable
preparations for further investigation of sweat
gland physiology. Not only were these dyes
excreted readily by the eecrine sweat glands but
they were of low toxicity and had been ad-
ministered locally and intravenously in the past
(7, 8). We then proceeded with a study of other
factors affecting dye excretion in eccrine sweat.
TABLE J**
Concentration Excretion in Sweat
%
I. Azo DyesOrange G. 0.05
Nitrazine 0.05
Janus Green B 0.05
Sudan IV* 0.05
Sudan Black B* 0.05
Congo Red 0.05—1.0
Trypan Red 0.05
Evans Blue 0.05
Trypan Blue 0.05
Direct Sky Blue 0.05
Methyl Orange 0.05
II. Anthroquinone Dyes
Alizarin Red 0.05
Alizarin 0.05
III. Thiazole Dyes
Titan Yellow 0.05
IV. Quinon.e-Imine Dyes
A. Thiazins
Thionin* 0.05-0.01 —
Azure A 0.05-0.01
Azure B 0.05 +
Azure C 0.05 +
Methylene Blue 0.05 +
Methylene Blue, zinc-free 0.05 +
Methylene Violet* 0.05-0.01 —
Toluidine Blue 0 0.05 +
B. Oxazins
Brilliant Cresyl Blue 0.05 +
Nile Blue A 0.05 +
Cresyl Violet 0.05 —
C. Azins
Neutral Red 0.05 +
Safranin 0.05 —
Nigrosin* 0.05 —
V. Phenyl-Methane Dyes
Fast Green FCF 0.05 —
Basic Fuchsin 0.05-0.2 —
Gentian Violet 0.05
Acid Fuchsin* 0.05-0.5 —
Light Green SQ 0.05 —
VI. Xanthenes
Rhodamine G 0.05-0.1 —
Fluorescein 0.01—5.0 +
EosinY 0.05 —
Bromchlorphenol Blue 0.05 —
Bromphenol Blue (sodium salt) 0.05 —
Chlorphenol Red (sodium salt) 0.05 —
Phenolsulphonphthalein 0.05—0.5 —
Acrifiavine 0.05 —
VII. Natural Dyes
Indigo Carmine 0.05
Hematoxylin* 0.05—0.01
VIII. Miscellaneous Dyes
Nitro Blue Tetrazolium* 0.05—0.01
** Classification of dyes based on that devised by Conn (17).
* Insoluble or poorly soluble in water.
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If. Studies with Methylene Blue
In many of the subsequent studies with
methylene blue, a standard "single-shot" prep-
aration combining the dye and the pharmacologic
agents, piocarpine or physostigrnine was used.
A buffered diluent (pH—7.2) was employed in
this preparation and the 0.05% concentration
of methylene blue and 1:1,000 concentration of
the drugs maintained in the final solution.
Interestingly, the highly oxidized methylene
blue prevented the oxidative alteration of the
physostigrnine which so readily occurs when the
drug is prepared in saline or other vehicles.
A. Effect of Rate of Sweating Upon Dye Excretion
In the earlier studies of the various dyes for
their exeretability by the sweat glands, we had
noted a definite difference in the sweating re-
sponse and dye excretion to the cholinergic
compounds, piocarpine and physostigmine. In
these studies 0.03 cc. of 0.05% methylene blue
was introduced into the test areas, 1 inches
apart, of the mid-portion of one forearm. After
an interval of 5—10 minutes, 0.03 cc. of the
cholinergic drugs in 1:1,000 concentration, was
injected into the dye-treated sites. Charac-
teristically, the piocarpine droplets were larger
and more faintly stained (Fig. 1), although when
first seen as small droplets emerging from the
sweat duct pore some droplets were occasionally
more intensely blue. At the physostigmine sites,
however, smaller sweat droplets, of more uniform
size and more deeply tinted with blue dye were
seen regularly (Fig. 2). Each response began
within 5—15 minutes, and lasted for 25—40 min-
utes, gradually diminishing over this period.
This test was repeated on more than 100 subjects
during the dye-screening studies and the above-
described findings were observed quite consist-
ently. Similar studies with these pharmacologic
stimuli were done using symmetrical sites on
opposite forearms in an additional 25 subjects,
with comparable findings recorded. It had been
reasoned that a difference in sweating responses
might be explained on the basis of area variation
in glandular activity even though the compared
test sites were only 13 inches apart on the same
forearm.
Further studies were then carried out using
progressively weaker concentrations of the drugs,
pilocarpine, acetylcholine, acetyl B-methacholine
(mecholyl®) and physostigmine. Again the
forearm was used as the test area. In all of these
studies 0.03 cc. of 0.05% methylene blue was
introduced initially into all of the test areas as
in the prior experiments. In the first series of
tests, 0.03 cc. physostigmine in increasing con-
centrations (1:10,000, 1:500,000 and 1:1,000,-
000) was introduced successively into three dye-
treated sites of the volar aspect of one forearm
of five subjects. The opposite forearm was
similarly treated in symmetrical areas with an
equivalent amount of the same concentrations
of pilocarpine. With the onset of sweating in these
areas it was observed that with the weaker
concentrations (1:500,000—1:1,000,000) of pi-
locarpine, the sweating response more clearly
resembled that seen after 1:1,000 physostigmine,
i.e., smaller, more deeply stained blue droplets.
The sweating response to physostigmine at the
weaker concentrations (1:500,000—1:1,000,000)
was poor or absent, with few droplets being
produced.
Similar studies were then done comparing
physostigmine with acetylcholine in 1:10,000,
1:500,000 and 1:1,000,000 concentrations in five
additional volunteers. Again the weak response
to physostigmine was noted. Acetylcholine, like
the pilocarpine, was also seen to induce smaller,
more deeply-stained blue sweat droplets at the
sites treated with weaker concentrations of the
drug. An occasional axon reflex type of response
was seen with these weaker concentrations of
acetyicholine.
Finally, in a third group of five subjects,
physostigmine was compared to acetyl-B metha-
choline in a fashion similar to that described
above in the two preceding experiments. The poor
sweating response to physostigmine was again
observed. The lower concentrations of mecho]yl
also produced decreased sweating responses, but
with droplets more deeply stained with blue
dye. It was noted, however, that the sweating
response to 1:1,000,000 mecholyl was generally
very weak and less regular than that seen in
response to equivalent concentrations of pi-
locarpine and acetyicholine.
In four additional subjects, 1:2,000,000 pi-
locarpine was given into methylene blue-treated
areas. Although the sweating response was poor
in two of these subjects, in the other two a
definite response, with small sweat droplets of
rather uniform size and deeply tinted with blue
dye, was observed.
FIG. 1. Excretion of Methylene Blue After Pilocarpine. Blue-stained eccrine sweat droplets of moder-
ate to large size shown above appeared after injection of 0.03 cc. of 0.05% methylene blue and 1:1,000
pilocarpine nitrate into the skin of the volar forearm. Variation in size of droplets and concentration of
dye can be observed. Dark central background represents tissue deposit of methylene blue.
FIG. 2. Excretion of Methylene Blue After Physostigmine. Ten minutes after the local introduction
of 0.03 cc. of 0.05% methylene blue and 1:1,000 physostigmine salicylate into the skin of the volar fore-
arm, the blue-tinted sweat droplets were observed. Note the intense blue staining of rather uniformly
small droplets. Lymphatic spread of the injected dye with blue sweat droplets peripheral to central
injection wheal is evident also.
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After studying the dye excretion in sweat
after pharmacologic stimulation, we then exam-
ined the effect of general heat on this response.
Four subjects were placed in a hot box (96° F.)
and profuse thermal sweating induced. Two
areas, one on the abdomen and one on the volar
forearm had been treated with 0.03 cc. of 0.05%
methylene blue. It is to be noted that these
areas were covered with castor oil as was routine
with these studies. Larger sweat droplets ap-
peared quite promptly in response to this stimu-
lus with faint blue staining seen. Occasionally
smaller droplets, more deeply tinted with blue
dye were seen at the early period of sweating.
In general, however, this intense form of stimula-
tion induced a profuse outpouring of sweat
lightly or poorly stained with methylene blue.
COMMENT
As a result of the above studies with pharma-
cologic stimuli and general thermal stimulation
it was concluded that the concentration of dye
in the eccrine sweat varied inversely with the
rate of sweating. The more profuse the sweating
or the greater the rate of sweating, the more
reduced was the dye concentration in the sweat
seen on the skin surface.
B. Effect of Other Sweating Stimuli
1. Emotional Stimulation. In five subjects,
5—10 minutes after the introduction of 0.03 cc.
of 0.05% methylene blue into the skin of the
hypothenar eminence of one palm, a 21 gauge
needle was inserted into the volar skin of the
opposite hand to induce emotional eccrine sweat-
ing of the palm. The excretion of methylene blue
in almost all of the sweat droplets was readily
observed (Fig. 3). The droplets were uniform in
size and rather heavily stained with methylene
blue. Similar studies using deep breathing or
mental arithmetic as the sweat stimulus in an
additional four subjects were also carried out
with a comparable response noted.
. Effect of Direct Heat. Non-nervous eccrine
Fin. 3. Excretion of Methylene Blue by Palmar Sweat Glands. Numerous blue puncta representing
methylene blue-stained sweat droplets are seen on palmar skin after emotional stimulation of sweating.
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FIG. 4. Dilution of Excreted Methylene Blue With Profuse Sweating. The above photograph was
taken 20 minutes following the local introduction of the standard methylene blue (0.05%)-pilocarpine(1:1,000) solution into the skin of the back. Observe the large sweat droplets with little or no visible dye
as produced by these more responsive glands. Unfortunately the black and white photographs do not
allow for easy visualization of the lightly-stained blue sweat droplets.
sweating, as elicited by direct thermal stimula-
tion of a skin region, was also induced in methyl-
ene-blue treatcd sites of the upper back in four
subjects. An infra-red lamp with built-in re-
flector (Westinghouse) was used as the heat
source and was placed 30 inches from the skin.
The test areas were covered with castor oil as
is routine in these studies, and after an interval
of 6—S minutes during which time the skin
temperature of the heated area rose (41°—43° C.),
small sweat droplets, moderately or heavily
stained with methylene blue were observed.
The stimulation was not extended beyond this
initial response because of danger of burning the
skin.
C. Area, Individual and Racial Variation
There was no significant variation in the ability
of the eccrine sweat glands of different areas to
excrete methylene blue. Areas tested included
the upper and lower extremities, abdomen, back,
chest, palms, and axillae. In all sites excretion of
dye could be observed after an appropriate
sweating stimulus. However, the relative re-
sponsiveness of the sweat glands in the various
areas did influence the intensity of the stimulus
required to induce sweating. The concentration
of dye seen in the sweat droplets was affected in
turn. On the posterior calf, for example, 1:1,000
physostigmine elicited a poor sweating response
in all of five subjects tested. Thus, little or no
blue sweating was observed. However, the in-
jection of 1:1,000 pilocarpine into the sym-
metrical region of the opposite calf in these
individuals induced easily-visualized blue sweat
droplets. The latter response was comparable
to that observed with 1:1,000 physostigmine on
the volar forearm as described above. In the
other areas tested, physostigmine (1:1,000)
was an adequate sweating stimulus and generally
produced a response comparable to that of the
volar forearm. In these areas, however, as on
S
266 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
the forearm, pilocarpine (1: 1,000), in all of seven
subjects tested, induced a more profuse type of
sweating with reduced dye concentration per
droplet (Fig. 4). In the axilla, emotional sweating
incident to the anxiety produced by the mere
local injection of the methylene blue, was often
observed and resulted in blue eccrine sweating
in this area.
Individual variation in excretion of methylene
blue in eccrine sweat did not appear to be signifi-
cant. Although a poor response was seen in an
occasional subject, this effect was more the
result of variation in ability to sweat, rather
than any difference in the excretion of dye. In
short, in those subjects in whom eccrine sweating
was poor in the test areas examined, methylene
blue staining of sweat droplets was not as uni-
form or dramatic as in the majority of individuals
studied. We found no subjects in whom there
was constant failure to excrete methylene blue.
Because of their darker skin which provided
a background of poorer contrast with the blue
dye, Negroes did not seem to excrete as much
blue sweat as did the White subjects. However,
close visualization of the test areas led us to
conclude that the Negro showed little if any
racial variation from that of the White in the
ability to excrete methylene blue in eccrine
sweat. Because of the difficulty with visualization
of the color, however, the darker skinned Negro
was not a good subject for studies with methylene
blue. We studied no other racial groups for this
activity.
COMMENT
These studies led us to conclude that the
eccrine sweat glands of all skin areas are capable
of readily excreting methylene blue. In areas in
which the sweat glands were inherently less
responsive, however, as on the calf, stronger
pharmacologic stimuli were required to produce
a rate of sweating equivalent to that seen with
weaker stimulation of more responsive glands of
other regions. This variation was not one in-
volving excretion of dye but related rather to
glandular reactivity or responsiveness in different
areas.
Individual variation in sweating and excretion
of dye was also noted, although constant or com-
plete failure to excrete methylene blue in any
subject was not recorded. No significant racial
variation in excretion of methylene blue was
observed, although the dye was poorly visualized
against dark Negro skin, giving the impression
of reduced dye excretion.
D. Effect of Electrolytes and pH
The prior introduction of certain electrolytes
into the skin test areas of five subjects failed to
influence significantly the excretion of methylene
blue in eccrine sweat. Areas on the volar forearm
were injected with 0.05 cc. of 3% NaC1, 3% KC1,
2% CaC12 and 2% MgCl2. Five to ten minutes
later, 0.03 cc. of 1:1,000 physostigmine-
methylene blue (0.05%) solution was introduced
and the areas observed for sweating. A control
area on the forearm without preliminary inj cc-
tion of salt solution also received the physostig-
mine-methylene blue injection. No appreciable
difference in the eccrine sweating response was
observed in the test areas of any of the subjects.
The effect of pH upon the excretion of methyl-
ene blue in eccrine sweat was also explored.
Samples of methylene blue solution, 0.05%,
were buffered to pH 5, 6, 7, 8 with phosphate
buffer. After standing overnight, the solutions
were tested with a pH meter prior to use in these
experiments to insure their stability. On the
volar forearm of five subjects 0.03 cc. of the
buffered dye solutions were introduced into
symmetrical test areas, followed 5—10 minutes
later by 0.03 cc. of 1: 1,000 physostigmine into
each site. Sweating ensued as usual in all of the
treated areas with no significant variation in
excretion of methylene blue noted. It should be
mentioned here that the 0.05% methylene blue
solution in isotonic saline without any buffer
has a pH of 4—5. This was also excreted readily
by the sweat glands.
E. Effect of Hyaluronidase Upon Dye Excretion
In four subjects tested, the preliminary (15—
20 minutes) introduction of 150 T.R.U.* of
hyaluronidase into a dye-treated area of the
forearm resulted in the excretion of faintly stained
blue sweat droplets after physostigmine (1:1,000)
stimulation. A control site receiving only methyl-
ene blue and physostigmine in equivalent concen-
trations showed more deeply stained blue
droplets. However, it was noted that at the sites
treated with hyaluronidase, spreading of the
dye was considerably greater and there was ap-
* Turbidity reducing units.
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parent lowered dye concentration in the sweat.
Moreover, there was little or no "injection wheal"
at the hyaluronidase-treated sites.
In another set of experiments, four additional
White subjects were similarly treated with 150
T.R.U. of hyaluronidase and physostigmine in-
jected fifteen minutes later. However, in this
group a small plastic ring covering an area one
inch in diameter was taped over the test areas
under light pressure sufficient to impede lym-
phatic spread of the injected materials. A control
area on the opposite forearm, treated identically
except for the plastic ring, was observed for
comparison. More diffuse staining of the skin
was noted in the "ring" sites. In addition, an
increased number of blue sweat droplets, i.e.,
blue sweat droplets over almost the entire skin
area encompassed by the ring, were seen. A
tendency toward increased concentration of the
dye in the sweat as indicated by more deeply
stained blue sweat droplets, was also apparent
in the "ring" sites, although a striking increase
was not noted.
COMMENT
The more rapid diffusion of the dye after
hyaluronidase is not surprising. Concentration
of the "spreading effect" of the hyaluronidase
within the study area was the objective in the
experiments in which the plastic ring was applied.
The contained hyaluronidase produced more
complete diffusion of dye, resulting in a more
uniform distribution of methylene blue through-
out the treated zone. This allowed for an in-
creased number of blue sweat droplets over a
wider area. It was felt that an increased concen-
tration of dye in the sweat droplets was evident
also, possibly as a result of increased permeability
of the basement membrane and/or cell mem-
branes of the secretory tubule as effected by the
hyaluronidase. Further studies are necessary to
confirm these interpretations, however.
F. Effect of Arrest of Circulation
In six volunteers the application of a sphyg-
monanometer cuff to one arm at a pressure just
above the systolic blood pressure after the intra-
dermal injection of 0.03 cc. of 0.05 buffered
mcthylene blue-physostigmine (1:1,000) solu-
tion into a test area of the forearm. A delayed
sweating response was noted, as compared to a
site on the opposite forearm without arrest of
the circulation. With release of the sphyg-
momanometcr cuff, the sweating response was
prompt and within three to five minutes could
not be distinguished from that of the control
(unobstructed) arm.
COMMENT
Inhibition of sweating after interruption of the
circulation has been carefully described recently
by Collins, Sargent and Weiner (9). The prompt
recovery of the glands of the obstructed arm, as
indicated by initial increased sweating rates and
excretion of dye in the sweat, could reflect a
compensatory response similar to the cutaneous
reactive hyperemia seen after vascular occlusion
of a limb.
G. Excretion in Apocrine Sweat
The injection of 0.03 cc. of 0.05% buffered
mcthylene blue solution in the shaved axillae of
five volunteers was made in an effort to deter-
mine the exeretibility of this dye by the apoerine
sweat gland. Injection of 0.03 cc. of 1:1,000
epinephrine solution into these dye-treated sites
resulted in the appearance of turbid white apo-
criue sweat droplets. No blue apocrine sweat
droplets were visualized. Repeat studies with
epinephrine four days later in these sites again
resulted in the appearance of the normal turbid
white apocrine sweat droplets without any
evidence of methylene blue. The addition of an
oxidizing agent failed to produce any color change
in the apocrine sweat droplets.
H. Systemic Administration of Methylene Blue
The oral or intravenous administration of
methylene blue in reasonable concentrations,
1—2%, did not result in a high enough concen-
tration of the dye in the skin to be visualized
readily in eccrine sweat. Moreover, possible
undesirable toxic effects of increased concen-
trations of the dye discouraged our further studies
with this route of administration.
1. Miscellaneous Observations
Preliminary treatment of separate test areas
of five volunteers with 0.2 mg. of atropine sulfate
or scopolamine hydrobromide resulted in the
inhibition of sweating and the excretion of
mcthylcne blue in areas injected with our
standard pilocarpine or physostigmine-methylene
blue solutions.
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The effects of eccrine secretion upon the
oxidation-reduction potential of methylene blue
were also examined. Injection of the oxidized or
blue form of the dye always resulted in excretion
of blue dye in the sweat. The reduced or leuko
form of the dye was prepared by adding ascorbic
acid to the standard (0.05% methylene blue
solution). A 5% concentration of ascorbic acid
was required to reduce the methylene blue of
this solution to the colorless form. At room
temperature, in a closed bottle, this preparation
was stable in the reduced state for several days.
Intradermal injection of 0.03 cc. of this reduced
methylene blue solution in the test areas of four
volunteers produced considerable immediate local
irritation. However, it could be readily observed
that oxidation of the injected methylene blue by
the tissue occurred shortly after injection,
developing at the periphery of the injection wheal
initially and then spreading centrally. Stimulation
of sweating in these areas by piloearpine or
physostigmine generally resulted in blue sweat
droplets, although the sweating response was
somewhat reduced, especially in the central
region of the injection wheal where the sweating
response was either completely inhibited or too
weak to be significant. This apparently resulted
from the irritative effect of the ascorbic acid and
the reduced methylene blue solution.
Two additional White subjects were given
ascorbic acid orally in a dosage of 2 gm. daily for
seven days. Blood ascorbic acid levels in these
subjects at the end of this week ranged from 20—
29 mg.% as compared to normal levels (2—3
mg.%) in a control group of three White subjects
to whom no Vitamin C was administered. These
five subjects were then given methylene blue-
physostigmine injections intradermally in the
standard manner and the sweating responses
observed. No appreciable difference could be
observed in the color of the dye in the tissues or
in the sweat of all of these subjects.
In four subjects, in test areas of the back in
which anidrosis or miliaria had been produced
by the application of adhesive tape over a period
of 6—7 days, the injection of physotigmine-
methylene blue solution in the standard fashion
resulted in the absence of blue colored sweat
droplets at the sites of the obstructed sweat
duets. However, blue sweat droplets were vis-
ualized at the duetal orifices of many unob-
structed glands within the tape-treated areas.
III. Studies with Fluorescein
Solutions of fluoreseein sodium in isotonic
saline were prepared in concentrations of 5%
and 20% and stored in colored vials in a dark
room to obviate fading or decrease in the fluores-
cence of the dye. Further dilution of these stock
solutions was done in buffered (pH—7.2) saline
immediately prior to use. In all of the studies
with fluoreseein, fluorescence was observed after
exposure of the test areas to Wood light
(TJVL—3600 A). As in the studies with methylene
blue, castor oil was employed as a film over the
test areas to inhibit spreading and evaporative
loss of the sweat droplets. The weak intrinsic
fluorescence of the castor oil did not alter signifi-
cantly the visualization of the fluoreseein-stained
eeerine sweat droplets.
A. Local Introduction of Fluorescein
In fifteen subjects, 0.03 cc. of 5% fluorescein
sodium solution was introduced into symmetrical
sites of opposite forearms. The fluorescence of
the injected dye in the tissues could be readily
observed after exposure to ultraviolet light.
Subsequent intradermal injections of 1:1,000
piloearpine nitrate in one forearm and 1: 1,000
physostigmine salieylate in the opposite forearm
prompted ecerine sweating in each site.
In general, the piloearpine induced a more
consistent and greater excretion of fluorescein,
as indicated by the presence of an increased
number and size of the stained sweat droplets
and an increased concentration of the dye in the
sweat (Fig. 5). After physostigmine, smaller and
fewer sweat droplets, poorly stained with fluores-
eein were seen. As with methylene blue, the
fluoreseein and drug were slowly carried away
by the lymphaties from the injection site. Some
sweat droplets stained with fluoreseein were
evident in these new areas.
Because of the darker background, the fluores-
eein was somewhat better visualized in Negro
than in White skin although the dye was readily
excreted in the sweat of both racial groups.
Studies of sweat gland activity in various
areas were also performed with fluoreseein as in
the methylene blue experiments. In general, area
variation was again seen to reflect the variation
in sweating and requisite strength of stimulus
as pointed out in the methylene blue studies.
Decreasing concentrations of fluoreseein
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Fm. 5. Large Fluorescein-Stained Sweat Droplets After Piloearpine. After local introduction of
0.03 cc. of 5% fluorescein sodium into the skin of the volar forearm, the injection of 0.03 cc. of 1:1,000
pilocarpine prompted the above response. Upon exposure to ultra-violet light, the bright fluorescence
of the sweat droplets was seen. Note fainter fluorescence of injected dye in the tissues.
sodium were then studied in a series of experi-
ments involving ten additional volunteers. It
was found that with freshly prepared solutions
of fluorescein, the intradermal injection of 0.005%
solutions of the dye still resulted in easily ob-
served fluorescent material in the sweat. Below
this concentration some fluorescent dye could
be seen irregularly. For the majority of the
studies employing intradermal introduction of
fluorescein, concentratious of 0.05% to 0.5%
were employed and are recommended. No ap-
preciable difference in dye excretion is seen in
this range of concentrations.
COMMENT
It is apparent that it is the special property
of fluorescence itself which allows for ready ob-
servation of the excreted fluorescein in concentra-
tions well below that required to visualize methyl-
ene blue in the sweat. The significance of this
fact lies in the applicability of fluorescein to
the study of dye excretion in eccrine sweat
after intravenous administration of the dye.
B. Intravenous Administration of Fluorescein
In ten subjects, symmetrical sites of each
forearm received intradermal injections of 0.03 cc.
of 1: 1,000 physostigmine and 1:1,000 pilocarpine
nitrate respectively. Following this 5 cc. of 20%
fluorescein sodium solution in isotonic saline was
given intravenously. This injection was given
quickly over a period of ten to twelve seconds.
Each of the stimulated areas of the forearm had
been covered with castor oil in the manner de-
scribed previously. Exposure of the skin to ultra-
violet light revealed the appearance of the fluores-
cein in the lips, and the skin of the cheeks, trunk
and extremities within the circulation time of the
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individual, in all cases within twenty seconds
after injection of the dye. In the sites stimulated
with the cholinergie drugs, no dye was immedi-
ately seen, despite observable active ecerine
sweating. Within 2—5 minutes, however, dye was
seen to pool or collect in these areas, especially
at the sites treated with physostigmine. This
pooling or collection of the dye in these sites
was followed by the appearance of fluorescein-
tinted sweat droplets. Less collection or pooling
of the dye was noted at the pilocarpine sites and
fewer sweat droplets were also seen in these areas.
These studies were repeated in five additional
volunteers in whom the injection of physostig-
mine was delayed until 2—3 minutes following
the introduction of the fluorescein. Again, no
fluorescein-stained sweat droplets were seen until
visible pooling and increased concentration of the
dye in the tissues of these physostigmine-treated
sites was noted. As noted in the previous experi-
ments, however, fluorescence of the shin of these
stimulated zones as well as other areas of the
skin surface and the mucous membranes was
observed prompty (within 20 seconds) after
injection. This fluorescence was of lesser intensity
than that of the fluorescein-stained sweat droplets
but still was clearly evident.
cOMMENT
The pooling of fluorescein at the sites treated
with cholinergic drugs apparently reflects the
local vasodilatory effect of these compounds.
Increased vessel permeability may or may not
also have occurred at these injection sites. How-
ever, local vasodilatation was seen, presumably
also with increased blood flow to the sweat glands
of these sites. The lack of any visible fluorescein
in the sweat droplets until after pooling of dye
in the tissues (apparently subsequent to extrava-
sation of dye from the vessels) would seem to
indicate that direct exchange from the vessel
to the ecerine secretory cell does not occur. A
possible objection to this conclusion would be
that the initial concentration of the dye in the
sweat after possible vascular exchange was too
low to be visible. However, the diluted dye in
the blood stream was readily observed in the
cutaneous vascular network within seconds after
injection. This visualization, it should be added,
had the added visual barrier of the skin itself
unlike the appearance of fluorescein in sweat
droplets on the skin surface. Although these
studies may not be regarded as conclusive, they
strongly support the view that sweat is derived
from the extracellular fluid and not directly
from the blood.
nIscTJssION
Our observation of decreased concentration of
dye in the sweat with increased rates of sweating
should be considered further in view of the work
of Lobitz and Mason (10). These authors demon-
strated decreased concentration of most solutes
in profusely secreted sweat as compared to sweat
secreted slowly. This evidence supports the view
that ductal reabsorption of water takes place
in slowly secreted sweat. A similar interpretation
could be placed upon our finding of the variation
in dye concentration with different sweating
rates. However, an alternative explanation is
that mere dilution of dye occurs as increased
quantities of sweat are formed. This is a simpler
interpretation, of course, but it would obviate
the necessity of accounting for lack of evidence
supporting ductal reabsorption in profusely
secreted sweat. It should be added, however,
that there is considerable histochemical or an-
atomical evidence indicating functional activity
of the ecerine duct.
We have no evidence to indicate reabsorption
of dye by the sweat duct. It may be recalled that
Conn explained the decrease in sodium chloride
concentration in sweat during acclimatization
partly to reabsorption of salt (11).
To our knowledge, the use of injected dyes
to study eccrine sweat gland function in the
fashion described herein has not been described
previously. Kuno and his associates introduced
iontophoretically a series of dyes, including meth-
ylene blue, and examined the staining of the
sweat ducts and adjacent tissues (12). Interest-
ingly, they noted increased transudation of dye
into the surrounding tissues when the glands
were actively secreting. In an in vitro histo-
physiologic study, Sperling and Koppanyi ex-
amined the effect of secretory activity of eat
sweat glands upon the oxidative state of methyl-
lene blue (13). Functioning sweat glands pre-
vented reduced methylene blue from turning bhie,
while resting glands did not. Others have been
unable to confirm these observations (14). Our
studies with human skin revealed no reduction
of methylene blue by functioning sweat glands.
In our opinion, the issue of whether the in-
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jected dyes are secreted or excreted by the sweat
glands is purely a semantic problem, at least
at this stage of our knowledge. Sweat contains
a number of substances, such as urea, ammonia,
lactate and sodium chloride along with the prin-
cipal component, water. Whether the gland is
excreting or secreting the various constituents is
arbitrary. We have elected to use the term
excretion in describing the presence of these dyes
in eccrine sweat. However, it is apparent that
this dye excretion reflects the secretory or func-
tional activity of the sweat gland.
The technic of dye clearance or excretion
by the sweat gland offers a novel approach to the
study of many phases of the functional activity
of the sweat glands in normals and in patients
with certain disease states. Any alteration in the
function of the secretory tubule or duct of the
sweat glands should result in an alteration of the
excretion of these dyes. Thus, the lack of sweating
in congenital ectodermal defect or in miliaria
could be readily confirmed. An obvious immediate
application of this technic is in the study of
cystic fibrosis patients. In such patients, the
excessive loss of electrolytes, sodium and chloride,
in the sweat, is a constant finding. It is con-
ceivable, if not likely, that excretion of dyes by
the sweat glands of these patients would also
show distinct variation from the normal. We are
currently studying this problem.
Correlative histologic and physiologic study
of the sweat glands after injection of various
dyes is a special aspect of our experimental
program which has been described in detail
elsewhere (15, 16).
SUMMARY AND CONCLUSION
A study of the excretion or "clearance" by the
eccrine sweat glands of locally and/or parenter-
ally administered dyes has been described. A
total of forty-four dyes, representing all of the
known groups of biological dyes of low toxicity,
were tested, with local pharmacologic stimulation
of sweating. The dyes which were excreted by
the sweat glands in sufficient concentration to be
readily visualized included Methylene Blue,
Azure B, Azure C, Toluidine Blue 0, Briffiant
Cresyl Blue, Nile Blue A, Neutral Red and
Fluorescein.
No chemical configuration common to all of
the excreted dyes which might explain their
excretion in sweat was noted. However, the
quinone-imine dyes, as a group, were outstanding
in that the majority of these dyes were excreted
by the sweat glands. The property of water-
solubiity of the dyes was found to be necessary
for excretion in ecerine sweat.
Additional studies with locally-introduced
methylene blue revealed that increased rates of
sweating produced reduced concentrations of dye
in the sweat. The significance of this finding in
relation to possible ductal reabsorption of water
was discussed. Area and individual variation
in the appearance of methylene blue in the sweat
reflected differences in the responsiveness of the
sweat glands or the ability to sweat, not in the
excretion of dye.
On most areas of the skin surface, 1:1,000
physostigmine induced easily-visualized excretion
of methylene blue most consistently and suitable
for wide-scale studies of this response.
Other types of eccrine sweating stimuli, e.g.,
emotional stimulation, direct and general heat,
were also found to induce excretion of locally-
introduced methylene blue in eccrine sweat.
Increase in the local tissue concentration of
certain electrolytes and alteration of the pH of
the dye solution produced no significant altera-
tion of the excretion of methylene blue in eccrine
sweat.
Local introduction of hyaluronidase enhanced
the diffusion of the injected dye to more sweat
glands within the local test area and seemed to
increase the concentration of dye excreted in the
sweat.
Methylene blue was not excreted by the
apocrine sweat gland.
Methylene blue was always excreted in the
oxidized or colored (blue) form, and attempts
to reduce the blue form in the tissues or to induce
excretion of the reduced (colorless) form of
methylene were fruitless. The dye was always
oxidized when detected in the sweat.
Preliminary local administration of anti-
cholinergic drugs blocked local eccrine sweating
and dye excretion.
In areas of experimentally produced anidrosis
or miliaria, excretion of methylene blue-stained
eccrine sweat was inhibited.
Excretion by the sweat glands of fluorescein
sodium locally or intravenously administered was
also described. After intravenous administration
of the dye it was found that fluorescent dye did
not appear in the sweat until there was visible
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pooling or collection of dye in the tissues at the
sites of cholinergie stimulation. This observation
supported the notion that sweat is derived from
the extra-cellular fluid and not directly from
the blood.
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DISCUSSION
HARVEY BLARK, (Miami, Florida): Did you
have an opportunity to watch these openings
to see if the dye came up through the coiled part
of the most superficial end of the duct, or whether
you could see it only after it had appeared on the
surface?
Dn. JOSEPH A. WITKOWSKI (in closing): We
have not employed the skin microscope routinely
in the visualization of the stimulated sites. Thus,
we haven't had an opportunity to study the
ductal opening carefully under sufficiently high
magnification to allow this observation.
